Clinical Trial Update: A Randomized Study of a Short Duration Therapy for Candidemia [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial is evaluating a short-duration therapy for candidemia; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: CANDIDEMIA | Phase 3 | Status: NOT_YET_RECRUITING